Kymera Therapeutics, Inc. · NASDAQ:KYMR

Baker Bros. Advisors LP reported a 9.50% stake in Kymera Therapeutics, Inc. (Schedule 13D/A)

Event Jun 26, 2025 · Filed Jun 30, 2025

Baker Bros. Advisors LP reported a 9.50% stake in Kymera Therapeutics, Inc., 6,666,540 shares, with active intent on Jun 26, 2025. Filed Jun 30, 2025 (Schedule 13D/A).

Stake
9.50%
Shares
6,666,540
Intent
Active
What changed
Stake changed
Filed together
4 holders

The filing in full

HolderStakeShares
Baker Bros. Advisors LP9.50%6,666,540
Baker Bros. Advisors (GP) LLC9.50%6,666,540
Julian C. Baker9.50%6,666,540
Felix J. Baker9.50%6,666,540

Source

View original at SEC

Related